Uric acid: what your result means.

Uric acid is the end product of purine metabolism. Elevated levels cause gout and kidney stones, and track closely with metabolic syndrome, insulin resistance and hypertension.

Why Uric acid matters

The evidence is a study in causal honesty: genetic analyses confirm urate directly causes gout, risk rises steeply with level, while its strong associations with cardiovascular disease appear largely to reflect shared metabolic dysfunction rather than direct causation. Either way, a rising urate is an early metabolic warning worth acting on.

Associated risks when out of range: Metabolic syndrome, Hypertension. Cardiovascular risk. Gout risk (when high).

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Uric acid, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Normative Aging Study (Campion et al. American Journal of Medicine 1987): gout incidence climbed steeply with serum urate, from ~0.5% per year at moderate elevations to ~5% per year above ~540 µmol/L, defining the risk gradient still quoted today.
• Mendelian randomisation analysis (White et al. Lancet Diabetes & Endocrinology 2016): genetically elevated urate showed no clear causal effect on coronary heart disease, the honest conclusion that urate's cardiovascular associations largely reflect shared metabolic dysfunction.
• Mechanistic and clinical review (Feig et al. NEJM 2008): synthesised the links between urate, hypertension and metabolic syndrome, supporting urate as an early metabolic warning marker even where direct causality is unproven.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets Uric acid against published clinical authority standards, never arbitrary "optimal" ranges. Measured in µmol/L:

Clinical interpretation

• Elevated uric acid is both a cause (gout, kidney stones) and a marker (metabolic syndrome, fructose excess).
• Strongly correlated with insulin resistance, often improves with metabolic interventions.
• Extremely low uric acid (<0.15 mmol/L) may indicate molybdenum deficiency or xanthine oxidase issues.

What improves it: the evidence-based levers

• Reduce fructose
• Reduce alcohol
• Weight reduction
• Hydration

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How Uric acid testing works at HodieLabs

Uric acid is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Campion EW, et al. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421–426.
2. White J, et al. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2016;4:327–336.
3. Feig DI, et al. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–1821.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.